Table 1 Characteristics of studies included in the meta-analysis
From: Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma: a meta-analysis
Author | Year | Country/ Region | Number of HCC (M/F), age | Number of controls (M/F), age | Number of DRB1 alleles studied | HLA genotyping method |
|---|---|---|---|---|---|---|
Donaldson[11] | 2001 | Hong Kong | 84(79/5),55 | 124(-/-), NA | 13 | PCR-SSOP |
De Re[12] | 2004 | Italy | 29(-/-), NA | 144(-/-), NA | 13 | PCR-SSP |
Yuan[13]# | 2004 | China | 10(-/-), NA | 50(30/20),43.7 ± 12.9 | 3 | PCR-SSP |
López-Vázquez[14] | 2004 | Spain | 46(27/19),62 ± 8 | 48(19/29),56 ± 12 | 11 | PCR-SSOP |
Yuan[15]# | 2005 | China | 10(-/-), NA | 50(30/20),43.7 ± 12.9 | 2 | PCR-SSP |
Kummee[16] | 2007 | Thai | 50(38/12), 57.5 ± 14.2 | 100(68/32),50.8 ± 13.9 | 2 | PCR-SSP |
El-Chennawi[17] | 2008 | Egypt | 50(45/5),51.16 ± 6.16 | 50(44/6),48.88 ± 9.22 | 11 | PCR-SSP |
Pan[18] | 2009 | China | 62(52/10),53.58 | 50(29/21),30.12 | 8 | PCR-SSP |